Garden Of Life, POM Wonderful Cases Help FTC Hone Decree Language
This article was originally published in The Tan Sheet
Executive Summary
When courts disagree with FTC counsel on health claims cases, the agency looks for takeaways it can use to sharpen consent decree language in the future, says FTC advertising practices official Richard Cleland.
You may also be interested in...
Regulatory News In Brief
FTC/Garden of Life case continues; FDA deems ForMor in violation of GMPs; Kanebo faulted for pharmaceutical GMP failures; CytoSport settles litigation over Muscle Milk labeling; USPlabs’ carb claim canned in NAD review; FDA extends comment time on FSMA tracking pilots.
Fair Standard Remains For Supplement, Drug Claim Substantiation – FTC
The Federal Trade Commission says consent orders that require more clinical tests to substantiate health claims than are required for other product categories are fair because they are based on the nature of the claims, agency officials say.
LaneLabs Harnesses Science, Expert Support To Prevail Over FTC
A supplement firm's victory over the Federal Trade Commission in federal court demonstrates the rigorous expert support and claim substantiation necessary for thwarting legal challenges from regulators